Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-24-019344

VP, Pharmaceutical Development acquired 15,218 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cappello Joseph VP, Pharmaceutical Development 2024-02-19 Grant or award +3,661 9,396 D
Cappello Joseph VP, Pharmaceutical Development 2024-03-14 Grant or award +11,557 20,953 D
Loading xslF345X05/form4-07082024_040711.xml…